This study will compare the absolute and relative effectiveness of asthma management in
patients on inhaled corticosteroid (ICS) maintenance therapy as Easi-breathe® (EB) -
beclometasone dipropionate (BDP) breath-actuated inhaler (BAI) - and as-needed (prn) reliever
medication (short-acting beta2-agonist [SABA] therapy) via either a BAI (i.e. Easi-breathe®
[EB] salbutamol) or via a pressurised metered dose inhaler (MDI) (e.g. MDI salbutamol).